Skip to main content

Table 3 Summary of primary and secondary outcomes for the ChloraLockTM pilot trial

From: Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial

Pilot trial outcomes

Analysis

Pass threshold

 Primary outcomes

  1. Consent rate: patients and SDMs approached who consent to randomization

Proportion

≥ 80%

  2. Recruitment rate: eligible patients who are randomized

Proportion

≥ 80%

  3. Protocol adherence: times ChloraLockTM is used in conjunction with usual locking procedures

Proportion

≥ 90%

  4. Comfort: staff comfort level with the device and trial protocol

Descriptive

NA

 Secondary outcomes

  1. Central line colonization: assessed for each arm as positive central line culture and negative peripheral poke

Proportion

NA

  2. Bacteremia: assessed for each arm as positive stab cultures

Proportion

NA

  3. Clinical end points: LOS in ICU, LOS in hospital, ICU mortality at 28 days, hospital mortality at 28 days

Median or mean proportions

NA